Evidence map›Paper›PMID 42811112›Full record

ReviewNature reviews. Immunology2026

The effects of IFNγ on tissue physiology through structural cells.

Irah L King, Bana Jabri, Amanda W Lund, Andrew Wang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Irah L KingDepartment of Microbiology and Immunology and Department of Medicine, Meakins-Christie Laboratories, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada. irah.king@mcgill.ca.ORCID http://orcid.org/0000-0001-6990-7231
Bana JabriDepartment of Medicine, Committee on Immunology, Department of Pediatrics, Department of Pathology, University of Chicago, Chicago, IL, USA.
Amanda W LundRonald O. Perelman Department of Dermatology, Department of Pathology and Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-7389-9983
Andrew WangDepartment of Immunobiology and Department of Internal Medicine (Rheumatology, Allergy, and Immunology), Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-6951-8081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon-γ (IFNγ) is classically defined by its potent ability to enhance the antimicrobial and tumour-killing activities of innate and adaptive immune cells, establishing it as an archetypal pro-inflammatory type 1 cytokine. However, as the most conserved of the interferons throughout evolution, it is possible that IFNγ may have a more fundamental physiological role beyond these immune functions. A rapidly growing body of literature now indicates that IFNγ acts extensively on non-haematopoietic, structural cells to regulate organ function, tissue homeostasis and context-dependent immune adaptation. These findings position IFNγ as a primary coordinator of diverse defence strategies, including host resistance, disease tolerance and trained immunity. In this Perspective, we examine how IFNγ signalling in non-haematopoietic cells complements or alters its canonical immune functions and argue that defining the context-specific and cell-specific actions of IFNγ is essential to inform therapeutic approaches targeting IFNγ that enhance immunity while preserving tissue function.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.